23 February 2021 : Original article
Kidney Function After Liver Transplantation in a Single Center
Grzegorz Niewiński1ADEFG, Wiktor Smyk2B, Agata Graczyńska1B, Konrad Kostrzewa3C, Joanna Raszeja-Wyszomirska2ADEF*, Urszula Ołdakowska-Jedynak4DF, Jolanta Małyszko4DF, Maciej Wójcicki2DF, Krzysztof Zieniewicz5DEFDOI: 10.12659/AOT.926928
Ann Transplant 2021; 26:e926928
Table 4 Factors featuring the last recorded SCr during follow-up period.
| SCr ≥1.5 mg/dL | SCr <1.5 mg/dL | p-Value | |
|---|---|---|---|
| Age (years) | 63±13 | 54±19.5 | 0.007 |
| Serum sodium before LT (mmol/l) | 137.4±5.20 | 139.1±5.8 | 0.32 |
| SCr before LT (mg/dL) | 1.22±1.08 | 0.87±0.43 | 0.0037 |
| Colloids (mL) | 1500±900 | 900±600 | 0.018 |
| Crystalloids (mL) | 4200±1000 | 4000±1000 | 0.23 |
| Anhepatic phase (minutes) | 110±40 | 90±50 | 0.36 |
| Hypotonia (MAP ≤80 mmHg) (% of individuals) | 89 | 46 | 0.016 |
| Catecholamines usage during LT (n of patients) | 7 | 24 | 0.076 |
| Tacrolimus blood through level (ng/mL) | 7.4±6.55 | 9.4±6.8 | 0.458 |
| SCr – serum creatinine; MAP – mean arterial pressure. Data presented as median±IQR. | |||